The Sally W. Schwarz Award was created as a means of recognizing individuals who have made an outstanding contribution to the field of radiopharmacy. This contribution can be in the form of radiopharmaceutical development, production and/or translation of radiopharmaceuticals for nuclear medicine and molecular imaging, and/or significant contributions to the regulatory oversight of radiopharmaceutical supply and administration, and/or in the mentoring and education of the next generation of radiopharmacists. The Sally W. Schwarz Award carries with it an award of $1,000 supported by the Radiopharmaceutical Sciences Council.
A successful candidate will be chosen based on excellence or achievement in one or more of the following criteria:
- Outstanding achievement in pharmacy applied to radiopharmaceutical sciences in support of nuclear medicine and molecular imaging;
- Significant contribution to the development and translation of new radiopharmaceuticals to the clinic;
- Contributions to the development of radiopharmaceutical regulations, guidances, and/or quality control measures;
- Significant impact on the success of a radiopharmaceutical production site;
- Excellence in training and mentorship of the next generation of radiopharmacists ;
- Significant contributions on SNMMI-based projects related to radiopharmacy.
- The nominee must be a member of the RPSC in good standing
- The nominee must be a radiopharmacist or be qualified in radiopharmacy (including radiopharmaceutical technicians).
- The nominator is responsible for providing the following materials:
- Cover letter from the nominator highlighting the nominee’s excellence or achievement in one or more of the criteria outlined in the award description*;
- Two supporting letters in addition to the nomination letter;
- Current CV of the nominee;
- Photo of the nominee.
*Applicants not selected will have their applications rolled over for up to three years.